stocktools
Offerings // Akari Therapeutics Plc

AKTX offering history

Every offering-related filing in Akari Therapeutics Plc’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 743 filings back to Apr 13, 2012.

Last executed offering
May 22, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Jul 10, 2026
S-3/A — capacity, not a sale
Executed, last 12 months
3
424B pricings + 8-K 3.02 sales
Registered, last 12 months
7
S-1/S-3/F-series registrations
DateFilingWhat it means
Jul 13, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 10, 2026S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Jul 8, 2026S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Jul 7, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 2, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 26, 2026S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
May 22, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 21, 2026RW →WITHDRAWNRegistration withdrawn
May 8, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 15, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 29, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 23, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Dec 17, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 17, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 5, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 2, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 17, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Oct 16, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 16, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 29, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 29, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jul 31, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 29, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 14, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 14, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 6, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 3, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Nov 14, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Oct 11, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 11, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 16, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 13, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 6, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 4, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 11, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 2, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Oct 27, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 26, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 23, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 23, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
AKTX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full AKTX workspace →
AKTX offering FAQ

When did AKTX last execute an offering?

Per SEC filings, Akari Therapeutics Plc's most recent priced offering document is a 8-K filed 2026-05-22. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did AKTX last announce or register an offering?

The most recent registration is a S-3/A filed 2026-07-10. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.